BiotechTube
Home/Biond Biologics/Ori Shilo, MBA
OS

Ori Shilo, MBA

Co‑Founder & Chief Financial Officer

Biond Biologics

Therapeutic Areas

OncologyImmunology

Biond Biologics Pipeline

DrugIndicationPhase
BND-22 (SAR44481)Solid TumorsPhase 1/2
BND-35Solid TumorsPhase 1/2

Leadership Team at Biond Biologics

TB
Tehila Ben Moshe, Ph.D.
Co‑Founder, Chairperson & Chief Executive Officer
YS
Yair Sapir, Ph.D., MBA
Chief Operations Officer
IM
Ilana Mandel, Ph.D.
Chief Scientific Officer
View full Biond Biologics profile